Cargando...
Choosing ibrutinib wisely
In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).(1)
Gardado en:
| Publicado en: | Blood |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5757683/ https://ncbi.nlm.nih.gov/pubmed/29326348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-813907 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|